- Home
- NMS vs BYSI Comparison
NMS vs BYSI Comparison
Compare NMS & BYSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
HOLD
Current Price
$1.95
Company Overview
Basic Information| Metric | NMS | BYSI |
|---|---|---|
| Founded | 1993 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 71.2M | 79.0M |
| IPO Year | N/A | 2017 |
Fundamental Metrics
Financial Performance| Metric | NMS | BYSI |
|---|---|---|
| Price | $11.92 | $1.95 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 12.0K | ★ 639.6K |
| Earning Date | 01-01-0001 | 11-12-2025 |
| Dividend Yield | ★ 4.11% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.21 | $0.98 |
| 52 Week High | $12.18 | $3.44 |
Technical Indicators
Market Signals| Indicator | NMS | BYSI |
|---|---|---|
| Relative Strength Index (RSI) | 47.35 | 47.09 |
| Support Level | $11.84 | $1.89 |
| Resistance Level | $12.00 | $2.44 |
| Average True Range (ATR) | 0.07 | 0.19 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 45.36 | 14.75 |
Price Performance
Historical Comparison NMS
BYSI
About NMS Nuveen Minnesota Quality Municipal Income Fund
Nuveen Minnesota Quality Municipal Income Fund is a diversified closed-end management investment company. The Fund's primary investment objective is current income exempt from both regular federal income taxes and Minnesota state income taxes and its secondary investment objective is the enhancement of portfolio value.
About BYSI BeyondSpring Inc.
BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment.